Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
Print
Session VI: ALL
Impact of Minimal Residual Disease in the Treatment of Acute Lymphoblastic Leukemia
Thursday, May 12, 2022
12:05 PM – 12:25 PM
Speaker(s)
Selina Luger, MD
Professor of Medicine
Abramson Cancer Center
Philadelphia, Pennsylvania
Learning Objectives:
Discuss the appropriation of MRD data when establishing treatment algorithms for patients with ALL